Ribomic Inc (4591)

Currency in JPY
73.0
+3.0(+4.29%)
Closed·
Earnings results expected in 12 days
4591 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
68.073.0
52 wk Range
57.0127.0
Key Statistics
Bid/Ask
72.00 / 73.00
Prev. Close
70
Open
70
Day's Range
68-73
52 wk Range
57-127
Volume
862.7K
Average Volume (3m)
1.79M
1-Year Change
-24.7423%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4591 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Ribomic Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
14/05/2026
EPS / Forecast
-7.21 / --
Revenue / Forecast
3M / --
EPS Revisions
Last 90 days

4591 Income Statement

Compare 4591 to Peers and Sector

Metrics to compare
4591
Peers
Sector
Relationship
P/E Ratio
−3.6x−8.6x−0.3x
PEG Ratio
−0.43−0.230.00
Price/Book
1.5x3.1x2.6x
Price / LTM Sales
1,376.0x20.6x3.0x
Upside (Analyst Target)
-154.1%56.7%
Fair Value Upside
Unlock14.3%9.4%Unlock

Ribomic Inc. engages in the discovery and development of pharmaceutical compounds using RNA aptamers in Japan and Europe. The company develops RBM-007, which is in Phase III clinical trial for the treatment of achondroplasia; Phase II clinical trial for the treatment of wet age-related macular degeneration; and pre-clinical trial for the treatment of diabetic macular edema. It is also involved in the development of drugs in pre-clinical trial stage, including RBM-006 for the treatment of retinal disease, proliferative, vitreoretinopathy, glaucoma, and diabetic retinopathy; RBM-011 for the treatment of pulmonary arterial hypertension; RBM-003 for the treatment of heart failure; RBM-010 for the treatment of osteoarthritis; and RBM-009 for the treatment of severe asthma, as well as RBM-101, which is in discovery stage for the affinity purification of human IgG and Fc-fusion proteins. The company was incorporated in 2003 and is headquartered in Minato, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
8.88M15.70%648.31M
Public Companies & Retail Investors
47.67M84.30%3.48B
Total
56.55M100.00%4.13B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rakuten Investment Management, Inc.4.94%2,791,700203,794
Evo Fund3.76%2,128,400155,373

FAQ

What Is the Ribomic (4591) Stock Price Today?

The Ribomic stock price today is 73.0 JPY.

What Stock Exchange Does Ribomic Trade On?

Ribomic is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Ribomic?

The stock symbol for Ribomic is "4591."

What Is the Ribomic Market Cap?

As of today, Ribomic market cap is 4.13B JPY.

What Is Ribomic's Earnings Per Share (TTM)?

The Ribomic EPS (TTM) is -23.1.

When Is the Next Ribomic Earnings Date?

Ribomic will release its next earnings report on 13/08/2026.

From a Technical Analysis Perspective, Is 4591 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Ribomic Stock Split?

Ribomic has split 0 times.

How Many Employees Does Ribomic Have?

Ribomic has 25 employees.

What is the current trading status of Ribomic (4591)?

As of 01/08/2026, Ribomic (4591) is trading at a price of 73.0 JPY, with a previous close of 70.0 JPY. The stock has fluctuated within a day range of 68.0 JPY to 73.0 JPY, while its 52-week range spans from 57.0 JPY to 127.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.